Abe, K., Chiba, Y., Hattori, S., Tamazawa, A., Yoshimi, A., Katsuse, O., & Suda, A. (2020). Influence of plasma cytokine levels on the conversion risk from MCI to dementia in the Alzheimer’s disease neuroimaging initiative database. Journal of the Neurological Sciences, 414, 116829. https://doi.org/10.1016/j.jns.2020.116829

Article  CAS  PubMed  Google Scholar 

Alsadany, M. A., Shehata, H. H., Mohamad, M. I., & Mahfouz, R. G. (2013a). Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer’s disease. American Journal of Alzheimer’s Disease and Other Dementias, 28(1), 54–61. https://doi.org/10.1177/1533317512467680

Article  PubMed  Google Scholar 

Angelopoulos, P., Agouridaki, H., Vaiopoulos, H., Siskou, E., Doutsou, K., Costa, V., & Baloyiannis, S. I. (2008). Cytokines in Alzheimer’s disease and vascular dementia. International Journal of Neuroscience, 118(12), 1659–1672. https://doi.org/10.1080/00207450701392068

Article  CAS  PubMed  Google Scholar 

Baune, B. T., Ponath, G., Golledge, J., Varga, G., Arolt, V., Rothermundt, M., & Berger, K. (2008). Association between IL-8 cytokine and cognitive performance in an elderly general population–the MEMO-Study. Neurobiology of Aging, 29(6), 937–944. https://doi.org/10.1016/j.neurobiolaging.2006.12.003

Article  CAS  PubMed  Google Scholar 

Bawa, K. K., Krance, S. H., Herrmann, N., Cogo-Moreira, H., Ouk, M., Yu, D., Wu, C. Y., Black, S. E., Lanctôt, K. L., & Swardfager, W. (2020). A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease. Journal of Neuroinflammation, 17(1), 84. https://doi.org/10.1186/s12974-020-01750-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Björkqvist, M., Ohlsson, M., Minthon, L., & Hansson, O. (2012). Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer’s disease. PLoS ONE, 7(1), e29868. https://doi.org/10.1371/journal.pone.0029868

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boccardi, V., Paolacci, L., Remondini, D., Giampieri, E., Poli, G., Curti, N., Cecchetti, R., Villa, A., Ruggiero, C., Brancorsini, S., & Mecocci, P. (2019). Cognitive decline and Alzheimer’s disease in old age: A sex-specific cytokinome signature. Journal of Alzheimers Disease, 72(3), 911–918. https://doi.org/10.3233/jad-190480

Article  CAS  Google Scholar 

Bonotis, K., Krikki, E., Holeva, V., Aggouridaki, C., Costa, V., & Baloyannis, S. (2008). Systemic immune aberrations in Alzheimer’s disease patients. Journal of Neuroimmunology, 193(1–2), 183–187. https://doi.org/10.1016/j.jneuroim.2007.10.020

Article  CAS  PubMed  Google Scholar 

Bossu, P., Ciaramella, A., Salani, F., Bizzoni, F., Varsi, E., Di Iulio, F., Giubilei, F., Gianni, W., Trequattrini, A., Moro, M. L., & Bernardini, S. (2008). Interleukin-18 produced by peripheral blood cells is increased in Alzheimer’s disease and correlates with cognitive impairment. Brain Behavior and Immunity, 22(4), 487–492. https://doi.org/10.1016/j.bbi.2007.10.001

Article  CAS  PubMed  Google Scholar 

Bourgognon, J.-M., & Cavanagh, J. (2020). The role of cytokines in modulating learning and memory and brain plasticity. Brain and Neuroscience Advances, 4, 2398212820979802. https://doi.org/10.1177/2398212820979802

Article  PubMed  PubMed Central  Google Scholar 

Cacabelos, R., Alvarez, X. A., Fernández-Novoa, L., Franco, A., Mangues, R., Pellicer, A., & Nishimura, T. (1994). Brain interleukin-1 beta in Alzheimer’s disease and vascular dementia. Methods and Findings in Experimental and Clinical Pharmacology, 16(2), 141–151.

CAS  PubMed  Google Scholar 

Capogna, E., Watne, L. O., Sørensen, Ø., Guichelaar, C. J., Idland, A. V., Halaas, N. B., Blennow, K., Zetterberg, H., Walhovd, K. B., Fjell, A. M., & Vidal-Piñeiro, D. (2023). Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers—in cognitively unimpaired older adults. Brain, Behavior, and Immunity, 113, 56–65. https://doi.org/10.1016/j.bbi.2023.06.027

Article  CAS  PubMed  Google Scholar 

Cherbuin, N., Walsh, E., Baune, B. T., & Anstey, K. J. (2019). Oxidative stress, inflammation and risk of neurodegeneration in a population sample. European Journal of Neurology, 26(11), 1347–1354. https://doi.org/10.1111/ene.13985

Article  CAS  PubMed  Google Scholar 

Ciabattoni, G., Porreca, E., Di Febbo, C., Di Iorio, A., Paganelli, R., Bucciarelli, T., Pescara, L., Del Re, L., Giusti, C., Falco, A., & Sau, A. (2007). Determinants of platelet activation in Alzheimer’s disease. Neurobiology of Aging, 28(3), 336–342. https://doi.org/10.1016/j.neurobiolaging.2005.12.011

Article  CAS  PubMed  Google Scholar 

Cisbani, G., Koppel, A., Knezevic, D., Suridjan, I., Mizrahi, R., & Bazinet, R. P. (2020). Peripheral cytokine and fatty acid associations with neuroinflammation in AD and aMCI patients: An exploratory study. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2020.02.014

Article  PubMed  Google Scholar 

Contreras, J. A., Aslanyan, V., Sweeney, M. D., Sanders, L. M. J., Sagare, A. P., Zlokovic, B. V., & Pa, J. (2020). Functional connectivity among brain regions affected in Alzheimer’s disease is associated with CSF TNF-α in APOE4 carriers. Neurobiology of Aging, 86, 112–122. https://doi.org/10.1016/j.neurobiolaging.2019.10.013

Article  CAS  PubMed  Google Scholar 

Culjak, M., Perkovic, M. N., Uzun, S., Strac, D. S., Erjavec, G. N., Leko, M. B., & Pivac, N. (2020). The association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer’s disease. Current Alzheimer Research, 17(11), 972–984. https://doi.org/10.2174/1567205017666201130092427

Article  CAS  PubMed  Google Scholar 

De Luigi, A., Pizzimenti, S., Quadri, P., Lucca, U., Tettamanti, M., Fragiacomo, C., & De Simoni, M. G. (2002). Peripheral inflammatory response in Alzheimer’s disease and multiinfarct dementia. Neurobiology of Diseases, 11(2), 308–314. https://doi.org/10.1006/nbdi.2002.0556

Article  CAS  Google Scholar 

Delaby, C., Gabelle, A., Blum, D., Schraen-Maschke, S., Moulinier, A., Boulanghien, J., & Lehmann, S. (2015). Central nervous system and peripheral inflammatory processes in Alzheimer’s disease: Biomarker profiling approach. Frontiers in Neurology. https://doi.org/10.3389/fneur.2015.00181

Article  PubMed  PubMed Central  Google Scholar 

Doroszkiewicz, J., Kulczynska-Przybik, A., Dulewicz, M., Borawska, R., Krawiec, A., Slowik, A., & Mroczko, B. (2021). The cerebrospinal fluid interleukin 8 (IL-8) concentration in Alzheimer’s disease (AD). Alzheimer’s and Dementia, 17(S5), e051317. https://doi.org/10.1002/alz.051317

Article  Google Scholar 

Dubenko, O. E., Chyniak, O. S., & Potapov, O. O. (2021). Levels of proinflammatory cytokines IL-17 and IL-23 in patients with alzheimer’s disease, mild cognitive impairment and vascular dementia. Wiadomosci Lekarskie, 74(1), 68–71.

PubMed  Google Scholar 

Dursun, E., Gezen-Ak, D., Hanağası, H., Bilgiç, B., Lohmann, E., Ertan, S., & Yılmazer, S. (2015). The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer’s disease, mild cognitive impairment or Parkinson’s disease. Journal of Neuroimmunology, 283, 50–57. https://doi.org/10.1016/j.jneuroim.2015.04.014

Article  CAS  PubMed  Google Scholar 

Fenoglio, C., Galimberti, D., Lovati, C., Guidi, I., Gatti, A., Fogliarino, S., & Scarpini, E. (2004). MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiology of Aging, 25(9), 1169–1173. https://doi.org/10.1016/j.neurobiolaging.2003.11.008

Article  CAS  PubMed  Google Scholar 

Forlenza, O. V., Diniz, B. S., Talib, L. L., Mendonça, V. A., Ojopi, E. B., Gattaz, W. F., & Teixeira, A. L. (2009). Increased serum IL-1beta level in Alzheimer’s disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 28(6), 507–512. https://doi.org/10.1159/000255051

Article  CAS  PubMed  Google Scholar 

Fu, P., Peng, F., Alzheimer’s Disease Neuroimaging. (2022). CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia. PLoS ONE, 17(10), e0274503. https://doi.org/10.1371/journal.pone.0274503

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., & Scarpini, E. (2006). Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease. Neurobiology of Aging, 27(12), 1763–1768. https://doi.org/10.1016/j.neurobiolaging.2005.10.007

Article  CAS  PubMed  Google Scholar 

Gezen-Ak, D., Dursun, E., Hanağası, H., Bilgiç, B., Lohman, E., Araz, Ö. S., & Yılmazer, S. (2013). BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer’s disease or mild cognitive impairment. Journal of Alzheimers Disease, 37(1), 185–195. https://doi.org/10.3233/jad-130497

Article